A dashboard to visualize the geographic distribution of incidence and prevalence of diseases by race and ethnicity in the United States using real-world data

被引：0
|
作者：
Dreyfus, Brian [1 ]
Rayavaram, Siva [1 ]
Ferri, Leticia [1 ]
Kuri, Lorena [1 ]
机构：
[1] Bristol Myers Squibb, New York, NY USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1002
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [21] GEOGRAPHIC VARIATION OF ANKYLOSING SPONDYLITIS (AS) DIAGNOSIS ANDTREATMENT IN THE UNITED STATES: A REAL-WORLD EVIDENCE STUDY
    Deodhar, A.
    Kruzikas, D.
    Zhou, L.
    Biljan, A.
    Saffore, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 734 - 735
  • [22] Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region
    Hittle, Michael
    Culpepper, William J.
    Langer-Gould, Annette
    Marrie, Ruth Ann
    Cutter, Gary R.
    Kaye, Wendy E.
    Wagner, Laurie
    Topol, Barbara
    LaRocca, Nicholas G.
    Nelson, Lorene M.
    Wallin, Mitchell T.
    JAMA NEUROLOGY, 2023, 80 (07) : 693 - 701
  • [23] Mortality Burden of Immune-Mediated Inflammatory Diseases (IMID): Race/Ethnicity, Sex, and Geographic Variation in the United States
    Singh, Ram
    Yen, Eric
    Wu, Meifang
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [24] A Novel Approach for Estimating Prevalence and Incidence for 100+Health Conditions by Race/ Ethnicity and County in the United States
    Gillespie, Kate W.
    Oron, Assaf P.
    Kendrick, Parkes
    Lei, Jiali
    Jonscher, Charles
    Roth, Greg A.
    Perez-Stable, Eliseo J.
    Mensah, George A.
    Mokdad, Ali
    Dwyer-Lindgren, Laura
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 96 - 96
  • [25] Real-World Talquetamab Utilization Patterns and Dose Schedules in the United States: An Analysis Using Claims Data
    Banerjee, Rahul
    Wang, Ruibin
    Liu, Yi-Hsuan
    He, Jinghua
    Le, Hoa H.
    Patel, Saurabh N.
    Zhang, Xinke
    BLOOD, 2024, 144 : 2392 - 2393
  • [26] USE OF REAL-WORLD DATA TO ESTIMATE PREVALENCE OF COMMERCIALLY-INSURED HIGH CARDIOVASCULAR RISK PATIENTS IN THE UNITED STATES
    Hardin, J.
    Quek, R. G.
    Roehl, K.
    Richhariya, A.
    Gandra, S. R.
    VALUE IN HEALTH, 2016, 19 (03) : A42 - A43
  • [27] EXPANDING THE USE OF REAL-WORLD DATA TO ANSWER CLINICAL PHARMACOLOGY QUESTIONS: DEVELOPMENT OF A USER-FRIENDLY DASHBOARD TO ASSESS PREVALENCE OF ORGAN IMPAIRMENT IN PATIENTS IN THE REAL-WORLD SETTING
    Vora, B.
    Velasquez, E.
    Zhang, R.
    Igras, K.
    James, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S58 - S58
  • [28] Incidence of Serious Infection Events in People With Chronic Neutropenia-Analysis of Real-World Data From Patients in the United States
    Tollefsen, Kylle
    Jin, Harry
    Connelly, James
    Newburger, Peter E.
    Walkovich, Kelly
    Cadavid, Diego
    Warren, Julia
    CLINICAL IMMUNOLOGY, 2023, 250 : 106 - 107
  • [29] A survey of United States adult privacy perspectives and willingness to share real-world data
    Hendricks-Sturrup, Rachele M.
    Lu, Christine Y. Y.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 7 (01)
  • [30] What quantifies good primary care in the United States? A review of algorithms and metrics using real-world data
    Wang, Yun
    Zheng, Jianwei
    Schneberk, Todd
    Ke, Yu
    Chan, Alexandre
    Hu, Tao
    Lam, Jerika
    Gutierrez, Mary
    Portillo, Ivan
    Wu, Dan
    Chang, Chih-Hung
    Qu, Yang
    Brown, Lawrence
    Nichol, Michael B.
    BMC PRIMARY CARE, 2023, 24 (01):
12345